Category
Neurocritical Care & Cardiac Arrest
Journal
Lancet
Takeaway
IV tenecteplase up to 24h after basilar occlusion: excellent outcome 38% vs 29% (NNT~11).
Verdict
Positive
Year
2026
Lancet
IV tenecteplase up to 24h after basilar occlusion: excellent outcome 38% vs 29% (NNT~11).